Mark R. Litzow

Also affiliated with WinnMed

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 67 papers. Top paper: “Long-term outcomes for ibrutinib–rituximab and chemoimmunotherapy in CLL: updated results of the E1912 trial”.

Long-term outcomes for ibrutinib–rituximab and chemoimmunotherapy in CLL: updated results of the E1912 trial

Blood(2022)10.1182/blood.2021014960

N/A

5.5DataRank · unranked

240 citations

Victoria Wang, Curtis A. Hanson, Elisabeth Paietta, Susan O’Brien, Jacqueline C. Barrientos +17 more

Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults

New England Journal of Medicine(2024)10.1056/nejmoa2312948

N/A

4.4DataRank · unranked

227 citations

Zhuoxin Sun, Ryan J. Mattison, Elisabeth Paietta, Kathryn G. Roberts, Yanming Zhang +37 more

Dasatinib/prednisone induction followed by blinatumomab/dasatinib in Ph+ acute lymphoblastic leukemia

Blood Advances(2022)10.1182/bloodadvances.2022008216

N/A

1.8DataRank · unranked

72 citations

Anna Moseley, Kristen M. O’Dwyer, Brent L. Wood, Jae H. Park, Matthew J. Wieduwilt +12 more

Pevonedistat with azacitidine in older patients with TP53-mutated AML: a phase 2 study with laboratory correlates

Blood Advances(2022)10.1182/bloodadvances.2022008625

N/A

0.839DataRank · unranked

19 citations

Scott H. Kaufmann, Eytan M. Stein, Prapti A. Patel, Maria R. Baer, Wendy Stock +35 more

Results of a phase 3 study of IVO vs IO for previously untreated older patients (pts) with chronic lymphocytic leukemia (CLL) and impact of COVID-19 (Alliance).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.7500

N/A

0.687DataRank · unranked

14 citations

Jun Yin, Jennifer R. Brown, Shira Dinner, Gerard Lozanski, Richard F. Little +15 more

Measurable residual disease by flow cytometry in acute myeloid leukemia is prognostic, independent of genomic profiling

Leukemia Research(2022)10.1016/j.leukres.2022.106971

N/A

0.613DataRank · unranked

9 citations

Zhuoxin Sun, Timour Baslan, Yanming Zhang, Mithat Gönen, Omar Abdel-Wahab +13 more

Late effects after ablative allogeneic stem cell transplantation for adolescent and young adult acute myeloid leukemia

Blood Advances(2020)10.1182/bloodadvances.2019001126

N/A

0.601DataRank · unranked

54 citations

Soyoung Kim, Heather R. Tecca, Stephanie Bo‐Subait, Rachel Phelan, Ruta Brazauskas +33 more

Chemotherapy-free treatment with inotuzumab ozogamicin and blinatumomab for older adults with newly diagnosed, Ph-negative, CD22-positive, B-cell acute lymphoblastic leukemia: Alliance A041703.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.7006

N/A

0.584DataRank · unranked

48 citations

Jun Yin, Oudom Kour, Rebecca Teske, Wendy Stock, Kenneth Byrd +12 more

Allogeneic hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a CIBMTR analysis

Blood Advances(2023)10.1182/bloodadvances.2023011308

N/A

0.483DataRank · unranked

24 citations

Mei‐Jie Zhang, Karen Chen, Sairah Ahmed, Uday Deotare, Siddhartha Ganguly +64 more

Measurable residual mutated IDH1 before allogeneic transplant for acute myeloid leukemia

Bone Marrow Transplantation(2024)10.1038/s41409-024-02447-4

N/A

0.480DataRank · unranked

10 citations

Niveditha Ravindra, Pranay S. Hegde, Georgia Andrew, Devdeep Mukherjee, Zoë C. Wong +18 more

Measurable residual mutated IDH2 before allogeneic transplant for acute myeloid leukemia

Bone Marrow Transplantation(2024)10.1038/s41409-024-02449-2

N/A

0.480DataRank · unranked

10 citations

Niveditha Ravindra, Pranay S. Hegde, Georgia Andrew, Devdeep Mukherjee, Zoë C. Wong +18 more

Comparison of outcomes of HCT in blast phase of BCR-ABL1− MPN with de novo AML and with AML following MDS

Blood Advances(2020)10.1182/bloodadvances.2020002621

N/A

0.449DataRank · unranked

19 citations

Soyoung Kim, Zhen‐Huan Hu, Ying Liu, Mahmoud Aljurf, Ulrike Bacher +37 more

Obesity in adult acute myeloid leukemia is not associated with inferior response or survival even when dose capping anthracyclines: An ECOG‐ACRIN analysis

Cancer(2023)10.1002/cncr.34807

N/A

0.400DataRank · unranked

8 citations

Zhuoxin Sun, Catherine Lai, Hugo F. Fernández, Larry D. Cripe, Rhett P. Ketterling +11 more

A Phase 2 Study of Dasatinib, Prednisone, and Blinatumomab for Older Patients with Philadelphia-Chromosome (Ph) Positive or Ph-like Acute Lymphoblastic Leukemia (ALL) (with Dasatinib Sensitive Fusions/ Mutations)

Blood(2021)10.1182/blood-2021-145529

N/A

0.396DataRank · unranked

13 citations

Anna Moseley, Kristen O'Dwyer, Brent Wood, Jae H Park, Matthew Wieduwilt +12 more

Measurable residual FLT3 tyrosine kinase domain mutations before allogeneic transplant for acute myeloid leukemia

Bone Marrow Transplantation(2024)10.1038/s41409-024-02444-7

N/A

0.306DataRank · unranked

6 citations

Georgia Andrew, Gege Gui, Niveditha Ravindra, Devdeep Mukherjee, Zoë C. Wong +15 more

A phase 1 trial of venetoclax in combination with liposomal vincristine in patients with relapsed or refractory B‐cell or T‐cell acute lymphoblastic leukemia: Results from the ECOG‐ACRIN EA9152 protocol

eJHaem(2024)10.1002/jha2.991

N/A

0.297DataRank · unranked

5 citations

Ju‐Whei Lee, David F. Claxton, Elisabeth Paietta, Hassan B. Alkhateeb, Jae H. Park +8 more

Tolerability and long-term disease control by IGHV mutation status among patients with CLL on ibrutinib arm of E1912

Blood Advances(2025)10.1182/bloodadvances.2024013474

N/A

0.292DataRank · unranked

6 citations

Victoria Wang, Curtis A. Hanson, Elisabeth Paietta, Susan O’Brien, Jacqueline C. Barrientos +16 more

Measurable Residual IDH1 before Allogeneic Transplant for Acute Myeloid Leukemia

medRxiv(2023)10.1101/2023.07.28.23293166

N/A

0.184DataRank · unranked

2 citations

Laura W. Dillon, Niveditha Ravindra, Pranay S. Hegde, Georgia Andrew, Devdeep Mukherjee +17 more

Pre-MEASURE: FLT3 -ITD and mutated NPM1 measurable residual disease before allogeneic transplant in adults with AML in first remission

medRxiv(2022)10.1101/2022.10.21.22281322

N/A

0.126DataRank · unranked

1 citations

Gege Gui, Niveditha Ravindra, Zoë C. Wong, Georgia Andrew, Devdeep Mukherjee +16 more

Prognostic effect of gender on outcome of treatment for adults with acute myeloid leukaemia

British Journal of Haematology(2021)10.1111/bjh.17523

N/A

0DataRank · unranked

20 citations

Zhuoxin Sun, Larry D. Cripe, Jacob M. Rowe, Hugo F. Fernández, Selina M. Luger +5 more

Perceptions of Hematology Among Palliative Care Physicians: Results of a Nationwide Survey

Journal of Pain and Symptom Management(2021)10.1016/j.jpainsymman.2021.04.021

N/A

0DataRank · unranked

14 citations

Daniel S. Childs, Kelly L. Wu, Daniel K. Partain, Mark R. Litzow, Thomas W. LeBlanc +2 more

Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML

Blood Advances(2021)10.1182/bloodadvances.2021004881

N/A

0DataRank · unranked

13 citations

Alexandra Gomez-Arteaga, Rafael Madero‐Marroquin, Mei‐Jie Zhang, Khalid Bo-Subait, J. Ortiz Sánchez +51 more

Tipifarnib as maintenance therapy did not improve disease-free survival in patients with acute myelogenous leukemia at high risk of relapse: Results of the phase III randomized E2902 trial

Leukemia Research(2021)10.1016/j.leukres.2021.106736

N/A

0DataRank · unranked

6 citations

Victoria X. Wang, Jacob M. Rowe, Mark R. Litzow, Elisabeth Paietta, Rhett P. Ketterling +11 more

Enhancer retargeting of CDX2 and UBTF::ATXN7L3 define a subtype of high-risk B-progenitor acute lymphoblastic leukemia

Blood(2022)10.1182/blood.2022015444

N/A

0DataRank · unranked

51 citations

Lindsey E. Montefiori, Ilaria Iacobucci, Yaqi Zhao, Qingsong Gao, Elisabeth Paietta +31 more

Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113 AML patients

Leukemia(2022)10.1038/s41375-022-01738-3

N/A

0DataRank · unranked

21 citations

Mei‐Jie Zhang, Karen Chen, Hisham Abdel‐Azim, Muhammad Bilal Abid, Mahmoud Aljurf +47 more

SF3B1-mutant myelodysplastic syndrome/myeloproliferative neoplasms: a unique molecular and prognostic entity

Haematologica(2022)10.3324/haematol.2021.280463

N/A

0DataRank · unranked

8 citations

Terra L. Lasho, Christy M. Finke, Rhett P. Ketterling, Kaaren K. Reichard, Kristen McCullough +16 more

Pre-MEASURE: Multicenter evaluation of the prognostic significance of measurable residual disease testing prior to allogeneic transplantation for adult patients with AML in first remission.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.7006

N/A

0DataRank · unranked

11 citations

Laura W. Dillon, Gege Gui, Niveditha Ravindra, Zoë C. Wong, Georgia Andrew +15 more

Stromal-induced epithelial-mesenchymal transition induces targetable drug resistance in acute lymphoblastic leukemia

Cell Reports(2023)10.1016/j.celrep.2023.112804

N/A

0DataRank · unranked

33 citations

Hiroki Yoshihara, Qingsong Gao, Chunxu Qu, Ilaria Iacobucci, Pankaj S. Ghate +16 more

Association between the choice of the conditioning regimen and outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis

Haematologica(2023)10.3324/haematol.2022.281958

N/A

0DataRank · unranked

33 citations

Soyoung Kim, Noel Estrada‐Merly, Muhammad Bilal Abid, Mahmoud Aljurf, Amer Assal +44 more

A simple prognostic system in patients with myelofibrosis undergoing allogeneic stem cell transplantation: a CIBMTR/EBMT analysis

Blood Advances(2023)10.1182/bloodadvances.2023009886

N/A

0DataRank · unranked

20 citations

Donal P. McLornan, Kwang Woo Ahn, Noel Estrada‐Merly, Juan Carlos Hernández‐Boluda, Sergio Giralt +46 more

Epigenomic mapping reveals distinct B cell acute lymphoblastic leukemia chromatin architectures and regulators

Cell Genomics(2023)10.1016/j.xgen.2023.100442

N/A

0DataRank · unranked

16 citations

Robert J. Mobley, Jonathan D. Diedrich, Brennan P. Bergeron, Kashi Raj Bhattarai, Alexander C. Monovich +20 more

Phase 1/1b study of azacitidine and hedgehog pathway inhibitor sonidegib in patients with myeloid neoplasms

Cancer(2023)10.1002/cncr.34800

N/A

0DataRank · unranked

8 citations

Heidi Kosiorek, Amylou C. Dueck, Jeanne Palmer, Lisa Sproat, James M. Bogenberger +6 more

SINGLE CELL DISSECTION OF DEVELOPMENTAL ORIGINS AND TRANSCRIPTIONAL HETEROGENEITY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.12.04.569954

N/A

0DataRank · unranked

17 citations

Andy G.X. Zeng, Qingsong Gao, Laura García‐Prat, Pradyuamna Baviskar, Sayyam Shah +20 more

Epigenomic mapping in B-cell acute lymphoblastic leukemia identifies transcriptional regulators and noncoding variants promoting distinct chromatin architectures

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.02.14.528493

N/A

0DataRank · unranked

3 citations

Robert J. Mobley, Jonathan D. Diedrich, Brennan P. Bergeron, Kashi Raj Bhattarai, Wenjian Yang +16 more

Functional investigation of inherited noncoding genetic variation impacting the pharmacogenomics of childhood acute lymphoblastic leukemia treatment

medRxiv(2023)10.1101/2023.02.10.23285762

N/A

0DataRank · unranked

0 citations

Robert J. Mobley, Kelly R. Barnett, Daniel C. Ferguson, Baranda S. Hansen, Jonathan D. Diedrich +19 more

Data from TET2 and DNMT3A Mutations Exert Divergent Effects on DNA Repair and Sensitivity of Leukemia Cells to PARP Inhibitors

(2023)10.1158/0008-5472.c.6513157.v1

N/A

0DataRank · unranked

0 citations

Bac Viet Le, Margaret Nieborowska-Skorska, Konstantin Golovine, Katherine Sullivan-Reed, Wangisa M.B. Dunuwille +30 more

Measurable Residual FLT3 Internal Tandem Duplication Before Allogeneic Transplant for Acute Myeloid Leukemia

JAMA Oncology(2024)10.1001/jamaoncol.2024.0985

N/A

0DataRank · unranked

54 citations

Gege Gui, Niveditha Ravindra, Georgia Andrew, Devdeep Mukherjee, Zoë C. Wong +20 more

Single-cell systems pharmacology identifies development-driven drug response and combination therapy in B cell acute lymphoblastic leukemia

Cancer Cell(2024)10.1016/j.ccell.2024.03.003

N/A

0DataRank · unranked

35 citations

Yizhen Li, Jingliao Zhang, Lei Yan, Huanbin Zhao, Liang Ding +21 more

Comparing venetoclax in combination with hypomethylating agents to hypomethylating agent-based therapies for treatment naive TP53-mutated acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)

Blood Cancer Journal(2024)10.1038/s41408-024-01000-2

N/A

0DataRank · unranked

31 citations

Ahmad Nanaa, Ehab Atallah, Rory M. Shallis, Sacchi de Camargo Correia Guilherme, Aaron D. Goldberg +12 more

Impact of Age on Pharmacogenomics and Treatment Outcomes of B-Cell Acute Lymphoblastic Leukemia

Journal of Clinical Oncology(2024)10.1200/jco.24.00500

N/A

0DataRank · unranked

17 citations

Zhenhua Li, Yoshihiro Gocho, Wenjian Yang, Kristine R. Crews, Shawn H.R. Lee +21 more

Investigation of inherited noncoding genetic variation impacting the pharmacogenomics of childhood acute lymphoblastic leukemia treatment

Nature Communications(2024)10.1038/s41467-024-48124-4

N/A

0DataRank · unranked

8 citations

Robert J. Mobley, Kelly R. Barnett, Daniel C. Ferguson, Baranda S. Hansen, Jonathan D. Diedrich +20 more

A Multicenter Analysis of Allogeneic Transplant Outcomes in Adults with Philadelphia-Like B-Cell Acute Lymphoblastic Leukemia in First Complete Remission

Transplantation and Cellular Therapy(2024)10.1016/j.jtct.2024.09.020

N/A

0DataRank · unranked

7 citations

Tamer Othman, Rima M. Saliba, Yenny Alejandra Moreno Vanegas, Razan Mohty, Celina Ledesma +18 more

Survival following allogeneic transplant in patients with myelofibrosis

Blood Advances(2020)10.1182/bloodadvances.2019001084

N/A

0DataRank · unranked

97 citations

Karen K. Ballen, Kwang Woo Ahn, Zhen‐Huan Hu, Haris Ali, Murat O. Arcasoy +63 more

Long-term survival can be achieved in a significant fraction of older patients with core binding factor acute myeloid leukemia treated with intensive chemotherapy

Haematologica(2024)10.3324/haematol.2024.285448

N/A

0DataRank · unranked

4 citations

Erika Borlenghi, Mark R. Litzow, John C. Byrd, Cristina Papayannidis, Cristina Tecchio +34 more

Shorter long-term post-transplant life expectancy may be due to prior chemotherapy for the underlying disease: analysis of 3012 patients with acute myeloid leukemia enrolled on 9 consecutive ECOG-ACRIN trials

Bone Marrow Transplantation(2024)10.1038/s41409-024-02308-0

N/A

0DataRank · unranked

1 citations

Yihua Wang, Kevin Roopcharan, Zijie Sun, Jacob M. Rowe, Hugo F. Fernández +9 more

Differentiation-dependent EBF1 activity determines CD22 transcription and leukemia sensitivity to inotuzumab ozogamicin

Blood(2025)10.1182/blood.2024028215

N/A

0DataRank · unranked

7 citations

Zhenhua Li, Kelly R. Barnett, Yizhen Li, Megan Walker, Satoshi Yoshimura +16 more

Measurable residual mutated NPM1 before allogeneic transplant for acute myeloid leukemia

Bone Marrow Transplantation(2025)10.1038/s41409-025-02757-1

N/A

0DataRank · unranked

2 citations

Gege Gui, Niveditha Ravindra, Georgia Andrew, Devdeep Mukherjee, Zoë C. Wong +23 more

Derivation and external validation of a venous thromboembolism risk prediction model in asparaginase-treated ALL

Blood Advances(2025)10.1182/bloodadvances.2025017862

N/A

0DataRank · unranked

0 citations

Radhika Gangaraju, Wafik G. Sedhom, Eva N. Hamulyák, Tzu‐Fei Wang, Kristen M. O’Dwyer +30 more

Temporal trends in critical care utilization and outcomes in allogeneic hematopoietic stem cell transplant recipients

Annals of Hematology(2024)10.1007/s00277-023-05612-9

N/A

0DataRank · unranked

7 citations

Domenic Ochal, William J. Hogan, Hassan Al-Khateeb, David P. Sklar, Svetlana Herasevich +8 more

Integrative genomic analyses reveal mechanisms of glucocorticoid resistance in acute lymphoblastic leukemia

Nature Cancer(2020)10.1038/s43018-020-0037-3

N/A

0DataRank · unranked

94 citations

Steven W. Paugh, Robert Carter, Lei Shi, Jingjing Liu, Daniel C. Ferguson +36 more

Incidence, Risk Factors for and Outcomes of Transplant‐Associated Thrombotic Microangiopathy

British Journal of Haematology(2020)10.1111/bjh.16457

N/A

0DataRank · unranked

94 citations

Ang Li, Brent R. Logan, Caitrin Fretham, Saurabh Chhabra, Mahmoud Aljurf +15 more

Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report

Blood Advances(2020)10.1182/bloodadvances.2019001266

N/A

0DataRank · unranked

36 citations

Rajneesh Nath, Jan Černý, Hai-Lin Wang, Mei-Jie Zhang, Hisham Abdel‐Azim +80 more

Prognostic impact and timing considerations for allogeneic hematopoietic stem cell transplantation in chronic myelomonocytic leukemia

Blood Cancer Journal(2020)10.1038/s41408-020-00387-y

N/A

0DataRank · unranked

37 citations

Aasiya Matin, Abhishek A. Mangaonkar, Ryan M. Carr, Moritz Binder, Aref Al‐Kali +9 more

TGFβR-SMAD3 Signaling Induces Resistance to PARP Inhibitors in the Bone Marrow Microenvironment

Cell Reports(2020)10.1016/j.celrep.2020.108221

N/A

0DataRank · unranked

30 citations

Paulina Podszywalow‐Bartnicka, Silvia Maifrede, Katherine Sullivan-Reed, Margaret Nieborowska-Skorska, Konstantin Golovine +21 more

Rapid Donor Identification Improves Survival in High-Risk First-Remission Patients With Acute Myeloid Leukemia

JCO Oncology Practice(2020)10.1200/jop.19.00133

N/A

0DataRank · unranked

23 citations

Megan Othus, Guillermo Garcia‐Manero, Min Fang, Jerald P. Radich, David A. Rizzieri +24 more

A homozygous missense variant in UBE2T is associated with a mild Fanconi anemia phenotype

Haematologica(2020)10.3324/haematol.2020.259275

N/A

0DataRank · unranked

5 citations

Francis P. Lach, Kimberly A. Rickman, Alejandro Ferrer, Abhishek A. Mangaonkar, Tanya L. Schwab +10 more

Clinical utility of fluorescence in situ hybridization‐based diagnosis of BCR‐ABL1 like (Philadelphia chromosome like) B‐acute lymphoblastic leukemia

American Journal of Hematology(2020)10.1002/ajh.25729

N/A

0DataRank · unranked

6 citations

Ryan A. Knudson, Kathryn E. Pearce, Reid G. Meyer, Beth A. Pitel, Jess F. Peterson +23 more

Toxicity burden in older patients with chronic lymphocytic leukemia (CLL) receiving bendamustine with rituximab (BR) or ibrutinib (IB) regimens: Alliance A041202.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e20004

N/A

0DataRank · unranked

0 citations

Sumithra J. Mandrekar, Allison M. Booth, Wei Ding, Nancy L. Bartlett, Danielle M. Brander +15 more

Enhancer Hijacking Drives Oncogenic BCL11B Expression in Lineage-Ambiguous Stem Cell Leukemia

Cancer Discovery(2021)10.1158/2159-8290.cd-21-0145

N/A

0DataRank · unranked

193 citations

Sonja Bendig, Zhaohui Gu, Xiaolong Chen, Petri Pölönen, Xiaotu Ma +47 more

Network-based systems pharmacology reveals heterogeneity in LCK and BCL2 signaling and therapeutic sensitivity of T-cell acute lymphoblastic leukemia

Nature Cancer(2021)10.1038/s43018-020-00167-4

N/A

0DataRank · unranked

159 citations

Jingjing Liu, Jianzhong Hu, Wentao Yang, Neekesh V. Dharia, Jingliao Zhang +42 more

Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia

Blood Advances(2021)10.1182/bloodadvances.2021004916

N/A

0DataRank · unranked

77 citations

Leland Metheny, Mei‐Jie Zhang, Hailin Wang, Noel Estrada‐Merly, David I. Marks +72 more

TET2 and DNMT3A Mutations Exert Divergent Effects on DNA Repair and Sensitivity of Leukemia Cells to PARP Inhibitors

Cancer Research(2021)10.1158/0008-5472.can-20-3761

N/A

0DataRank · unranked

52 citations

Bac Viet Le, Margaret Nieborowska-Skorska, Konstantin Golovine, Katherine Sullivan-Reed, Wangisa M.B. Dunuwille +30 more

Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph-negative acute lymphoblastic leukemia in first complete remission: analysis from CALGB 10403 and the CIBMTR

Leukemia(2021)10.1038/s41375-021-01213-5

N/A

0DataRank · unranked

42 citations

Wendy Stock, Anjali S. Advani, Selina M. Luger, Richard A. Larson, Martin S. Tallman +22 more

Intracellular Cholesterol Pools Regulate Oncogenic Signaling and Epigenetic Circuitries in Early T-cell Precursor Acute Lymphoblastic Leukemia

Cancer Discovery(2021)10.1158/2159-8290.cd-21-0551

N/A

0DataRank · unranked

42 citations

Robert Alberó, Francesca Gianni, Pablo Perez-Duran, Hannah I. Miller, Adam L. Mackey +10 more

Measurable residual disease does not preclude prolonged progression-free survival in CLL treated with ibrutinib

Blood(2021)10.1182/blood.2020010146

N/A

0DataRank · unranked

35 citations

Curtis A. Hanson, Renee C. Tschumper, Connie Lesnick, Esteban Braggio, Elisabeth Paietta +17 more

Allogeneic Transplantation to Treat Therapy-Related Myelodysplastic Syndrome and Acute Myelogenous Leukemia in Adults

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.08.010

N/A

0DataRank · unranked

29 citations

Natalie S. Callander, Aric C. Hall, Mei-Jei Zhang, Khalid Bo-Subait, Hailin Wang +43 more

An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis

Bone Marrow Transplantation(2021)10.1038/s41409-021-01450-3

N/A

0DataRank · unranked

27 citations

Marcos de Lima, Krishna V. Komanduri, Trent Wang, Mei-Jie Zhang, Karen Chen +56 more